Novel ankyrin repeat-containing pseudogene

Novel ankyrin repeat-containing pseudogene (ENSG00000249495) is annotated as a *pseudogene*, meaning it is a non-functional copy of a gene that once encoded a protein, in this case, presumably an ankyrin repeat-containing protein[1]. Pseudogenes are classified based on their biogenesis as unitary, unprocessed (duplicated), or processed (retrotransposed) pseudogenes, but regardless of type, they lack the capacity to encode a full-length, functional protein due to disabling mutations or incomplete sequences[2][6]. Ankyrin repeat domains themselves mediate protein-protein interactions and are common in regulatory proteins, but pseudogenes with ankyrin repeats no longer contribute to these cellular processes[5][7]. The specific pseudogene ENSG00000249495 does not produce a known protein, is not a therapeutic target, and lacks known disease associations or interacting drugs[1][2][6]. There is no evidence of function, druggability, or therapeutic relevance for this pseudogene. Its inclusion as a "target" is likely incorrect. It should not be considered a receptor, enzyme, transporter, or other therapeutically actionable biomolecule[1][2][6].